Oxford’s Organox Raises A £25 Million Profusion To Expand Its Commercial Footprint And Make Transplant Organs More Widely Available
Oxford’s Organox Raises A £25 Million Profusion To Expand Its Commercial Footprint And Make Transplant Organs More Widely Available
07/17/23, 10:57 AM
Location
oxfordshireMoney raised
£25 million
Industry
biotechnology
health care
Investors
Lauxera Capital Partners
Oxford-based medtech firm OrganOx has raised £25 million in growth investment as it looks to expand its commercial footprint. The company was founded in Oxford, as a spin out of the university, in 2008 – it says this growth funding is a step in the direction of getting its ducks in a row for an IPO.
Company Info
Location
oxfordshire, england, united kingdom
Additional Info
OrganOx is a commercial stage organ technology company, spun out of the University of Oxford in 2008, dedicated to developing technologies to improve outcomes for patients with acute or chronic organ failure. The OrganOx metra is a normothermic machine perfusion (NMP) platform approved in the U.S., Europe, Canada, and Australia.